Novo Nordisk and Kallyope in Gut-Brain Pact

25.06.2018 - Danish drugmaker Novo Nordisk is collaborating with Kallyope, a US biotech focused on the gut-brain axis, to discover novel peptide therapeutics for obesity and diabetes. Kallyope...